nodes	percent_of_prediction	percent_of_DWPC	metapath
Stavudine—Blood disorder—Epirubicin—bone cancer	0.00598	0.00598	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Methotrexate—bone cancer	0.00587	0.00587	CcSEcCtD
Stavudine—Blood disorder—Doxorubicin—bone cancer	0.00553	0.00553	CcSEcCtD
Stavudine—Inflammation—Methotrexate—bone cancer	0.0055	0.0055	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Epirubicin—bone cancer	0.00549	0.00549	CcSEcCtD
Stavudine—Thinking abnormal—Epirubicin—bone cancer	0.00546	0.00546	CcSEcCtD
Stavudine—Cough increased—Epirubicin—bone cancer	0.00546	0.00546	CcSEcCtD
Stavudine—Respiratory failure—Methotrexate—bone cancer	0.00544	0.00544	CcSEcCtD
Stavudine—Neuropathy peripheral—Cisplatin—bone cancer	0.00533	0.00533	CcSEcCtD
Stavudine—Stomatitis—Cisplatin—bone cancer	0.0053	0.0053	CcSEcCtD
Stavudine—Conjunctivitis—Cisplatin—bone cancer	0.00529	0.00529	CcSEcCtD
Stavudine—Inflammation—Epirubicin—bone cancer	0.00515	0.00515	CcSEcCtD
Stavudine—Hepatobiliary disease—Cisplatin—bone cancer	0.00515	0.00515	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Doxorubicin—bone cancer	0.00508	0.00508	CcSEcCtD
Stavudine—Cough increased—Doxorubicin—bone cancer	0.00505	0.00505	CcSEcCtD
Stavudine—Thinking abnormal—Doxorubicin—bone cancer	0.00505	0.00505	CcSEcCtD
Stavudine—Hepatocellular injury—Epirubicin—bone cancer	0.005	0.005	CcSEcCtD
Stavudine—Abnormal dreams—Epirubicin—bone cancer	0.00494	0.00494	CcSEcCtD
Stavudine—Eructation—Epirubicin—bone cancer	0.00491	0.00491	CcSEcCtD
Stavudine—Mouth ulceration—Methotrexate—bone cancer	0.00483	0.00483	CcSEcCtD
Stavudine—Connective tissue disorder—Cisplatin—bone cancer	0.0048	0.0048	CcSEcCtD
Stavudine—Gynaecomastia—Methotrexate—bone cancer	0.00478	0.00478	CcSEcCtD
Stavudine—Inflammation—Doxorubicin—bone cancer	0.00477	0.00477	CcSEcCtD
Stavudine—Neuropathy—Epirubicin—bone cancer	0.00469	0.00469	CcSEcCtD
Stavudine—Hepatocellular injury—Doxorubicin—bone cancer	0.00462	0.00462	CcSEcCtD
Stavudine—Abnormal dreams—Doxorubicin—bone cancer	0.00457	0.00457	CcSEcCtD
Stavudine—Eructation—Doxorubicin—bone cancer	0.00454	0.00454	CcSEcCtD
Stavudine—Mouth ulceration—Epirubicin—bone cancer	0.00452	0.00452	CcSEcCtD
Stavudine—Diabetes mellitus—Methotrexate—bone cancer	0.00445	0.00445	CcSEcCtD
Stavudine—Neuropathy—Doxorubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Stavudine—Mental disability—Epirubicin—bone cancer	0.00433	0.00433	CcSEcCtD
Stavudine—Hepatic failure—Methotrexate—bone cancer	0.00431	0.00431	CcSEcCtD
Stavudine—Malnutrition—Cisplatin—bone cancer	0.00425	0.00425	CcSEcCtD
Stavudine—Flatulence—Cisplatin—bone cancer	0.00419	0.00419	CcSEcCtD
Stavudine—Mouth ulceration—Doxorubicin—bone cancer	0.00418	0.00418	CcSEcCtD
Stavudine—Diabetes mellitus—Epirubicin—bone cancer	0.00417	0.00417	CcSEcCtD
Stavudine—Hepatic function abnormal—Epirubicin—bone cancer	0.00415	0.00415	CcSEcCtD
Stavudine—Hepatic failure—Epirubicin—bone cancer	0.00404	0.00404	CcSEcCtD
Stavudine—Mental disability—Doxorubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Stavudine—Anaemia—Cisplatin—bone cancer	0.00393	0.00393	CcSEcCtD
Stavudine—Diabetes mellitus—Doxorubicin—bone cancer	0.00386	0.00386	CcSEcCtD
Stavudine—Hepatic function abnormal—Doxorubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Stavudine—Leukopenia—Cisplatin—bone cancer	0.00381	0.00381	CcSEcCtD
Stavudine—Hepatic failure—Doxorubicin—bone cancer	0.00373	0.00373	CcSEcCtD
Stavudine—Mood swings—Methotrexate—bone cancer	0.00367	0.00367	CcSEcCtD
Stavudine—Myalgia—Cisplatin—bone cancer	0.00362	0.00362	CcSEcCtD
Stavudine—Anxiety—Cisplatin—bone cancer	0.00361	0.00361	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.0036	0.0036	CcSEcCtD
Stavudine—Affect lability—Epirubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Stavudine—Mood swings—Epirubicin—bone cancer	0.00344	0.00344	CcSEcCtD
Stavudine—Nervous system disorder—Cisplatin—bone cancer	0.0034	0.0034	CcSEcCtD
Stavudine—Thrombocytopenia—Cisplatin—bone cancer	0.0034	0.0034	CcSEcCtD
Stavudine—Skin disorder—Cisplatin—bone cancer	0.00337	0.00337	CcSEcCtD
Stavudine—Hyperhidrosis—Cisplatin—bone cancer	0.00336	0.00336	CcSEcCtD
Stavudine—Dry skin—Epirubicin—bone cancer	0.00332	0.00332	CcSEcCtD
Stavudine—Anorexia—Cisplatin—bone cancer	0.00331	0.00331	CcSEcCtD
Stavudine—Affect lability—Doxorubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Stavudine—Pancreatitis—Methotrexate—bone cancer	0.00328	0.00328	CcSEcCtD
Stavudine—Mood swings—Doxorubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00316	0.00316	CcSEcCtD
Stavudine—Influenza—Epirubicin—bone cancer	0.00313	0.00313	CcSEcCtD
Stavudine—Dysuria—Methotrexate—bone cancer	0.00313	0.00313	CcSEcCtD
Stavudine—Neutropenia—Methotrexate—bone cancer	0.00313	0.00313	CcSEcCtD
Stavudine—Paraesthesia—Cisplatin—bone cancer	0.00312	0.00312	CcSEcCtD
Stavudine—Dry skin—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Stavudine—Pancreatitis—Epirubicin—bone cancer	0.00307	0.00307	CcSEcCtD
Stavudine—Decreased appetite—Cisplatin—bone cancer	0.00302	0.00302	CcSEcCtD
Stavudine—Bronchitis—Epirubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Stavudine—Gastrointestinal disorder—Cisplatin—bone cancer	0.003	0.003	CcSEcCtD
Stavudine—Depression—Methotrexate—bone cancer	0.00298	0.00298	CcSEcCtD
Stavudine—Pain—Cisplatin—bone cancer	0.00297	0.00297	CcSEcCtD
Stavudine—Dysuria—Epirubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Stavudine—Neutropenia—Epirubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Stavudine—Stomatitis—Methotrexate—bone cancer	0.00291	0.00291	CcSEcCtD
Stavudine—Conjunctivitis—Methotrexate—bone cancer	0.0029	0.0029	CcSEcCtD
Stavudine—Influenza—Doxorubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Stavudine—Sweating—Methotrexate—bone cancer	0.00286	0.00286	CcSEcCtD
Stavudine—Haematuria—Methotrexate—bone cancer	0.00285	0.00285	CcSEcCtD
Stavudine—Pancreatitis—Doxorubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Stavudine—Weight decreased—Epirubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Stavudine—Hyperglycaemia—Epirubicin—bone cancer	0.00283	0.00283	CcSEcCtD
Stavudine—Hepatobiliary disease—Methotrexate—bone cancer	0.00282	0.00282	CcSEcCtD
Stavudine—Bronchitis—Doxorubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Stavudine—Body temperature increased—Cisplatin—bone cancer	0.00274	0.00274	CcSEcCtD
Stavudine—Neuropathy peripheral—Epirubicin—bone cancer	0.00274	0.00274	CcSEcCtD
Stavudine—Jaundice—Epirubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Stavudine—Stomatitis—Epirubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Stavudine—Urinary tract infection—Epirubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Stavudine—Conjunctivitis—Epirubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Stavudine—Dysuria—Doxorubicin—bone cancer	0.00271	0.00271	CcSEcCtD
Stavudine—Neutropenia—Doxorubicin—bone cancer	0.00271	0.00271	CcSEcCtD
Stavudine—Hepatitis—Methotrexate—bone cancer	0.00268	0.00268	CcSEcCtD
Stavudine—Sweating—Epirubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Stavudine—Haematuria—Epirubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Stavudine—Pharyngitis—Methotrexate—bone cancer	0.00266	0.00266	CcSEcCtD
Stavudine—Hepatobiliary disease—Epirubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Stavudine—Weight decreased—Doxorubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Stavudine—Sinusitis—Epirubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Stavudine—Hyperglycaemia—Doxorubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Stavudine—Hypersensitivity—Cisplatin—bone cancer	0.00256	0.00256	CcSEcCtD
Stavudine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00253	0.00253	CcSEcCtD
Stavudine—Jaundice—Doxorubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Stavudine—Stomatitis—Doxorubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Stavudine—Rhinitis—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Stavudine—Conjunctivitis—Doxorubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Stavudine—Urinary tract infection—Doxorubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Stavudine—Hepatitis—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Stavudine—Hypoaesthesia—Epirubicin—bone cancer	0.0025	0.0025	CcSEcCtD
Stavudine—Asthenia—Cisplatin—bone cancer	0.00249	0.00249	CcSEcCtD
Stavudine—Pharyngitis—Epirubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Stavudine—Sweating—Doxorubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Stavudine—Haematuria—Doxorubicin—bone cancer	0.00247	0.00247	CcSEcCtD
Stavudine—Connective tissue disorder—Epirubicin—bone cancer	0.00247	0.00247	CcSEcCtD
Stavudine—Hepatobiliary disease—Doxorubicin—bone cancer	0.00245	0.00245	CcSEcCtD
Stavudine—Sinusitis—Doxorubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Stavudine—Chills—Methotrexate—bone cancer	0.00241	0.00241	CcSEcCtD
Stavudine—Diarrhoea—Cisplatin—bone cancer	0.00237	0.00237	CcSEcCtD
Stavudine—Mental disorder—Methotrexate—bone cancer	0.00235	0.00235	CcSEcCtD
Stavudine—Malnutrition—Methotrexate—bone cancer	0.00233	0.00233	CcSEcCtD
Stavudine—Rhinitis—Doxorubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Stavudine—Hepatitis—Doxorubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Stavudine—Hypoaesthesia—Doxorubicin—bone cancer	0.00231	0.00231	CcSEcCtD
Stavudine—Pharyngitis—Doxorubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Stavudine—Dysgeusia—Methotrexate—bone cancer	0.00229	0.00229	CcSEcCtD
Stavudine—Connective tissue disorder—Doxorubicin—bone cancer	0.00228	0.00228	CcSEcCtD
Stavudine—Back pain—Methotrexate—bone cancer	0.00226	0.00226	CcSEcCtD
Stavudine—Chills—Epirubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Stavudine—Vomiting—Cisplatin—bone cancer	0.00221	0.00221	CcSEcCtD
Stavudine—Mental disorder—Epirubicin—bone cancer	0.0022	0.0022	CcSEcCtD
Stavudine—Rash—Cisplatin—bone cancer	0.00219	0.00219	CcSEcCtD
Stavudine—Dermatitis—Cisplatin—bone cancer	0.00219	0.00219	CcSEcCtD
Stavudine—Malnutrition—Epirubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Stavudine—Anaemia—Methotrexate—bone cancer	0.00216	0.00216	CcSEcCtD
Stavudine—Flatulence—Epirubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Stavudine—Dysgeusia—Epirubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Stavudine—Back pain—Epirubicin—bone cancer	0.00211	0.00211	CcSEcCtD
Stavudine—Leukopenia—Methotrexate—bone cancer	0.00209	0.00209	CcSEcCtD
Stavudine—Chills—Doxorubicin—bone cancer	0.00208	0.00208	CcSEcCtD
Stavudine—Nausea—Cisplatin—bone cancer	0.00206	0.00206	CcSEcCtD
Stavudine—Cough—Methotrexate—bone cancer	0.00204	0.00204	CcSEcCtD
Stavudine—Mental disorder—Doxorubicin—bone cancer	0.00203	0.00203	CcSEcCtD
Stavudine—Malnutrition—Doxorubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Stavudine—Anaemia—Epirubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Stavudine—Flatulence—Doxorubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Stavudine—Arthralgia—Methotrexate—bone cancer	0.00199	0.00199	CcSEcCtD
Stavudine—Myalgia—Methotrexate—bone cancer	0.00199	0.00199	CcSEcCtD
Stavudine—Dysgeusia—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00197	0.00197	CcSEcCtD
Stavudine—Leukopenia—Epirubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Stavudine—Back pain—Doxorubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Stavudine—Cough—Epirubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Stavudine—Nervous system disorder—Methotrexate—bone cancer	0.00187	0.00187	CcSEcCtD
Stavudine—Anaemia—Doxorubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Stavudine—Thrombocytopenia—Methotrexate—bone cancer	0.00186	0.00186	CcSEcCtD
Stavudine—Myalgia—Epirubicin—bone cancer	0.00186	0.00186	CcSEcCtD
Stavudine—Arthralgia—Epirubicin—bone cancer	0.00186	0.00186	CcSEcCtD
Stavudine—Anxiety—Epirubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Stavudine—Skin disorder—Methotrexate—bone cancer	0.00185	0.00185	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Stavudine—Hyperhidrosis—Methotrexate—bone cancer	0.00184	0.00184	CcSEcCtD
Stavudine—Dry mouth—Epirubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Stavudine—Anorexia—Methotrexate—bone cancer	0.00182	0.00182	CcSEcCtD
Stavudine—Leukopenia—Doxorubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Stavudine—Cough—Doxorubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Stavudine—Nervous system disorder—Epirubicin—bone cancer	0.00175	0.00175	CcSEcCtD
Stavudine—Thrombocytopenia—Epirubicin—bone cancer	0.00175	0.00175	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Stavudine—Skin disorder—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Stavudine—Hyperhidrosis—Epirubicin—bone cancer	0.00172	0.00172	CcSEcCtD
Stavudine—Insomnia—Methotrexate—bone cancer	0.00172	0.00172	CcSEcCtD
Stavudine—Arthralgia—Doxorubicin—bone cancer	0.00172	0.00172	CcSEcCtD
Stavudine—Myalgia—Doxorubicin—bone cancer	0.00172	0.00172	CcSEcCtD
Stavudine—Anxiety—Doxorubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Stavudine—Paraesthesia—Methotrexate—bone cancer	0.00171	0.00171	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Stavudine—Anorexia—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Stavudine—Somnolence—Methotrexate—bone cancer	0.00169	0.00169	CcSEcCtD
Stavudine—Dry mouth—Doxorubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Stavudine—Dyspepsia—Methotrexate—bone cancer	0.00168	0.00168	CcSEcCtD
Stavudine—Decreased appetite—Methotrexate—bone cancer	0.00166	0.00166	CcSEcCtD
Stavudine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Stavudine—Fatigue—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Stavudine—Pain—Methotrexate—bone cancer	0.00163	0.00163	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Stavudine—Nervous system disorder—Doxorubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Stavudine—Thrombocytopenia—Doxorubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Stavudine—Insomnia—Epirubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Stavudine—Skin disorder—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Stavudine—Paraesthesia—Epirubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Stavudine—Hyperhidrosis—Doxorubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Stavudine—Somnolence—Epirubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Stavudine—Anorexia—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Stavudine—Dyspepsia—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Stavudine—Gastrointestinal pain—Methotrexate—bone cancer	0.00156	0.00156	CcSEcCtD
Stavudine—Decreased appetite—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Stavudine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Stavudine—Fatigue—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Stavudine—Pain—Epirubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Stavudine—Constipation—Epirubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Stavudine—Urticaria—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Stavudine—Body temperature increased—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Stavudine—Abdominal pain—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Stavudine—Insomnia—Doxorubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Stavudine—Paraesthesia—Doxorubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Stavudine—Somnolence—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Stavudine—Gastrointestinal pain—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Stavudine—Dyspepsia—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Stavudine—Decreased appetite—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Stavudine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Stavudine—Fatigue—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Stavudine—Urticaria—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Stavudine—Constipation—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Stavudine—Pain—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Stavudine—Abdominal pain—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Stavudine—Body temperature increased—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Stavudine—Hypersensitivity—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Stavudine—Asthenia—Methotrexate—bone cancer	0.00137	0.00137	CcSEcCtD
Stavudine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Stavudine—Pruritus—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Stavudine—Hypersensitivity—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Stavudine—Urticaria—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Stavudine—Abdominal pain—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Stavudine—Body temperature increased—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Stavudine—Diarrhoea—Methotrexate—bone cancer	0.0013	0.0013	CcSEcCtD
Stavudine—Asthenia—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Stavudine—Pruritus—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Stavudine—Dizziness—Methotrexate—bone cancer	0.00126	0.00126	CcSEcCtD
Stavudine—Diarrhoea—Epirubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Stavudine—Hypersensitivity—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Stavudine—Vomiting—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Stavudine—Rash—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Stavudine—Dermatitis—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Stavudine—Headache—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Stavudine—Asthenia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Stavudine—Dizziness—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Stavudine—Pruritus—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Stavudine—Vomiting—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Stavudine—Nausea—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Stavudine—Diarrhoea—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Stavudine—Rash—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Stavudine—Dermatitis—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Stavudine—Headache—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Stavudine—Dizziness—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Stavudine—Nausea—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Stavudine—Vomiting—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Stavudine—Rash—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Stavudine—Dermatitis—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Stavudine—Headache—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Stavudine—Nausea—Doxorubicin—bone cancer	0.00098	0.00098	CcSEcCtD
